v3.26.3
Condensed Statement of Cash Flows (Unaudited)
9 Months Ended
Sep. 30, 2026
USD ($)
Cash flows from operating activities:  
Net income $ 1,414,098
Adjustments to reconcile net income to net cash used in operating activities:  
Payment of operating expenses by Sponsor through promissory note – related party (non-cash) 147,259
Interest earned on investments held in Trust Account (1,691,682)
Change in fair value of over-allotment liability (110,400)
Changes in operating assets and liabilities:  
Other receivable (10,477)
Prepaid expenses 47,905
Prepaid insurance (72,625)
Long term prepaid insurance (47,831)
Accounts payable and accrued expenses 9,000
Deferred legal fee 134,535
Net cash used in operating activities (180,218)
Cash Flows from Investing Activities:  
Investment of cash in Trust Account (140,350,000)
Net cash used in investing activities (140,350,000)
Cash Flows from Financing Activities:  
Proceeds from sale of units, net of underwriting discounts paid 137,200,000
Proceeds from sale of private placement units 4,700,000
Proceeds from sale of representative shares 140
Due from sponsor (12,500)
Repayment of promissory note – related party (454,898)
Payment of offering costs (536,048)
Net cash provided by financing activities 140,896,694
Net change in cash 366,476
Cash, beginning of the period
Cash, end of the period 366,476
Non-cash investing and financing activities:  
Deferred offering costs included in accrued offering costs 479,365
Deferred offering costs paid through promissory note – related party 32,400
Prepaid expenses paid through promissory note 100,000
Accrued expenses paid through promissory note – related party 25,000
Over-allotment option liability 110,400
Deferred underwriting fee payable 4,900,000
Reclassification of accrued offering costs to deferred legal fee 241,483
Forfeiture of founder Shares 70
Accretion of Class A ordinary shares subject to possible redemption to redemption value $ 12,974,300